-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - proton beam’s precision apply to more common
conditions such as prostate cancer and non-small cell lung … cancer;
however, no evidence exists for the comparative effectiveness or harms
of this therapy.2 Financial … cancer†*
Esophageal
Other:
Ovarian
Vaginal
Bladder
Bony pelvis
Cervical … cancers
separately due to their high
frequency among proton
beam recipients. … A similar increase was observed
for prostate and lung cancers.
-
effectivehealthcare.ahrq.gov/products/radiation-brain-metastases/protocol
January 28, 2020 - cancer brain metastases included in our review from those on all lung cancers to those including only … patients with non-small cell lung cancer. … cancer; combination of melanoma, breast, and lung cancer; combination of cancer diagnoses)
Extent … the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA). … [Advances in diagnosis and treatment of brain metastases from the primary lung cancer].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - cancer brain metastases included in our
review from those on all lung cancers to those including only … patients with non-small cell
lung cancer. … cancer; combination of melanoma, breast, and lung cancer; combination of
cancer diagnoses)
o Extent … the graded prognostic assessment for
lung cancer using molecular markers (lung-molGPA). … [Advances in diagnosis and treatment of brain metastases from the
primary lung cancer].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
September 18, 2023 - August 2023 found that USPSTF-recommended cancer screenings for breast,
colorectal, cervical, and lung … cancer, have “…saved 12.2–16.2 million life-years since the
introduction of USPSTF recommendations,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - percent of beneficiaries
with erlotinib orders had a prior
cancer diagnosis indicative of
its use in lung … cancer (a labeled
indication), 69 percent had
diagnoses indicative of its use
in secondary malignancies … cancers, 54 percent of benefi-
ciaries with an order for bevacizumab did not have a cancer diagnosis … cancer. … cancer.
-
effectivehealthcare.ahrq.gov/health-topics/lung-diseases/
-
effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/04.html
June 08, 2018 - Prostate cancer is the second most common type of cancer to cause death in American men (lung cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - Proton-beam radiotherapy for early-stage lung cancer. … Hypofractionated proton beam radiotherapy for stage I
lung cancer. … Carbon ion radiotherapy for stage I non-small
cell lung cancer. … High-dose proton beam therapy for Stage I non-small-cell
lung cancer. … Proton irradiation for non-small cell lung cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - For non-small-cell lung cancer and
hepatocellular carcinoma, patients who either refused surgery or … For example, particle beam therapy was used
in patients with non-small cell lung cancer (most stage … Lung
cancer and ocular melanoma studies used “hypofractionated” approaches with the mean total
dose … Proton-
beam radiotherapy for early-stage lung
cancer. Chest 1999;116(5):1313-9.
25. … Hypofractionated proton beam radiotherapy
for stage I lung cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
January 01, 2020 - cancer screening Adults age 55 to 80 with a
smoking history
Rates of screening,
followup procedures … Lung cancer screening
9. Obesity in adults: screening and management
10. … neoplasms/ or
uterine cervical neoplasms/
25 exp Obesity/
26 Smoking/
27 exp "Tobacco … cancer
1 Healthcare Disparities/
2 "Health Services Needs and Demand"/
3 exp Health … Neoplasms/
26 (lung adj2 cancer).ti,ab,kw.
27 ((("small cell" or "non small cell") adj3
-
effectivehealthcare.ahrq.gov/products/decision-aids
September 09, 2011 - Localized Prostate Cancer
March 09, 2016
Decision Aid
Archived
Is Lung … Cancer Screening Right for Me?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-268-racial-disparities-health-healthcare-executive-summary.pdf
December 01, 2023 - 4 studies), guide
emergency department (ED) care decisions (3 studies), determine eligibility for
lung … cancer screening (3 studies), and determine eligibility for prostate cancer
screening (2 studies). … cancer, opioid
misuse, and postpartum depression; suitability for kidney and liver transplant; and … cancer (3 studies),
predict opioid misuse (1 study), predict risk of prostate cancer (2 studies), and … cancer, postpartum depression, or
opioid misuse.
-
effectivehealthcare.ahrq.gov/products/radiotherapy-proton-beam/research
May 07, 2012 - proton beam's precision apply to more common conditions such as prostate cancer and non-small cell lung … cancer; however, no evidence exists for the comparative effectiveness or harms of this therapy.
-
effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research
August 26, 2011 - percent of beneficiaries with erlotinib orders had a prior cancer diagnosis indicative of its use in lung … cancer (a labeled indication), 69 percent had diagnoses indicative of its use in secondary malignancies
-
effectivehealthcare.ahrq.gov/products/dyspnea-advanced-cancer/protocol
October 22, 2019 - Reviewers will abstract data when available by subgroups such as specific cancer types (lung cancer) … Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
November 01, 2009 - For non-small-cell lung cancer and
hepatocellular carcinoma, patients who either refused
surgery or were
-
effectivehealthcare.ahrq.gov/health-topics/lung-diseases?page=1
-
effectivehealthcare.ahrq.gov/health-topics/lung-diseases?page=2
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
April 01, 2013 - Lung
Cancer. 2012 Jul;77(1):224-31. PMID:
22369719.
42. Hartzband P, Groopman J. … Quality of life in lung cancer: Does
disclosure of the diagnosis have an impact? … Lung Cancer. 2004;43(2):175-82. PMID:
14739038.
70. Otani H, Morita T, Esaki T, et al. … Cella
Level: 2, State: Excluded
Refid: 1447, Erlotinib for advanced non-small-cell lung cancer in … Levin
Level: 2, State: Excluded
Refid: 1508, Symptom improvement in lung cancer patients treated
-
effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
November 01, 2020 - Most studies
included patients with lung cancer and chronic obstructive pulmonary disease, but we were